INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Lobbying registrant
WS

W STRATEGIES, LLC

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections11with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    BRISTOL MYERS SQUIBB COLDA RR 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    EXELIXIS, INC.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    GSK plcLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    GILEAD SCIENCES, INC.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    ASTRAZENECA PLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Medtronic plcLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Merck & Co., Inc.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    ABBOTT LABORATORIESLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    INCYTE CORPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Dyne Therapeutics, Inc.LDA RR 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    AbbVie Inc.LDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026